mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |